Targeting hepatitis C virus translation: Stopping HCV where it starts

Current Opinion in Investigational Drugs

Volumn 4, Issue 2, 2003, Pages 162-167

  Jubin, Ronald ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

Antiviral assay; Hepatitis C; IRES; Ribosome; Translation

Indexed keywords

AMINO ACID; ANTIBIOTIC AGENT; ANTIVIRUS AGENT; BETA GLOBIN; COMPLEMENTARY RNA; INITIATION FACTOR 1A; INITIATION FACTOR 3; INITIATION FACTOR 4A; INITIATION FACTOR 4E; INITIATION FACTOR 4F; INITIATION FACTOR 4G; LUCIFERASE; MAGNESIUM; MESSENGER RNA; NUCLEIC ACID; NUCLEOTIDE DERIVATIVE; PEGINTERFERON ALPHA; PLASMID DNA; PROTEIN; RECOMBINANT ALPHA INTERFERON; RIBAVIRIN; UNCLASSIFIED DRUG; VIRUS ENZYME; VIRUS PROTEIN; VIRUS RNA;

5' UNTRANSLATED REGION; ASSAY; BACTERIAL TRANSMISSION; BINDING AFFINITY; DRUG EFFICACY; DRUG RESPONSE; GENOTYPE; HEALTH CARE PLANNING; HEPATITIS C; HEPATITIS C VIRUS; INTERNAL RIBOSOME ENTRY SITE; NONHUMAN; POLYADENYLATION; REVIEW; RNA TRANSLATION; SCREENING; VIRUS GENE; VIRUS REPLICATION; VIRUS TRANSCRIPTION;

ANIMALS; DRUG EVALUATION, PRECLINICAL; HEPACIVIRUS; HEPATITIS C; HUMANS; PROTEIN BIOSYNTHESIS; RABBITS; RETICULOCYTES; RIBOSOMES;

EID: 0037301437     PISSN: 14724472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (35)

1. The World Health Report. World Health Organization (1998):55-56.
2. Tanaka Y, Hanada K, Mizokami M, Yeo AE, Shih JW, Gojobori T, Alter HJ: A comparison of the molecular clock of hepatitis C virus in the United States and Japan predicts that hepatocellular carcinoma incidence in the United States will increase over the next two decades. Proc Natl Acad Sci USA (2002) 99(24):15584-15589.
3. Smith DB, Pathirana S, Davidson F, Lawlor E, Power J, Yap PL, Simmonds P: The origin of hepatitis C virus genotypes. J Gen Virol (1997) 78(2):321-328.
4. Rosenberg S: Recent advances in the molecular biology of hepatitis C virus. J Mol Biol (2001) 313(3):451-464.
5. Blight KJ, Kolykhalov AA, Reed KE, Agapov EV, Rice CM: Molecular virology of hepatitis C virus: An update with respect to potential antiviral targets. Antivir Ther (1998) 3(Suppl 3):71-81. Descriptive review of all HCV therapeutic targets.
6. McHutchinson JG, Gordon SC, Schiff ER, Shiffman ML, Lee WM, Rustgi VK, Goodman ZD, Ling MH, Cort S, Albrecht JK: Interferon α-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis C. Hepatitis Interventional Therapy Group. N Engl J Med (1998) 339(21):1485-1492.
7. Glue P, Rouzier-Panis R, Raffanel C, Sabo R, Gupta SK, Salfi M, Jacobs S, Clement RP: A dose-ranging study of pegylated interferon α-2b and ribavirin in chronic hepatitis C. The Hepatitis C Intervention Therapy Group. Hepatology (2000) 32(3):647-653.
8. Hu KQ, Vierling JM, Redeker AG: Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection. J Viral Hepat (2001) 8(1):1-18. Extensive review examining factors of HCV pathogenesis and interferon treatment.
9. Spahn CM, Prescott CD: Throwing a spanner in the works: Antibiotics and the translational apparatus. J Mol Med (1996) 74(8):423-439. Mechanistic review of antibiotics targeting prokaryotic translational machinery.
10. Hershey JW, Merrick WC: Pathway and mechanism of protein synthesis. In: Translational Control of Gene Expression. Sonenberg N, Hershey JW, Mathews MB (Eds), Cold Spring Harbor Laboratory Press, NY, USA (2000):52-56. A 'must read' for anyone interested in translation.
11. Honda M, Beard MR, Ping LH, Lemon SM: A phylogenetically conserved stem-loop structure at the 5′ border of the internal ribosome entry site of hepatitis C virus is required for cap-independent viral translation. J Virol (1999) 73(2):1165-1174.
12. Kieft JS, Zhou K, Jubin R, Murray MG, Lau JY, Doudna JA: The hepatitis C virus internal ribosome entry site adopts an ion-dependent tertiary fold. J Mol Biol (1999) 292(3):513-529. Demonstration of ion requirements for IRES folding, which is essential for function.
13. Reynolds JE, Kaminski A, Carroll AR, Clarke BE, Rowlands DJ, Jackson RJ: Internal initiation of translation of hepatitis C virus RNA: The ribosome entry site is at the authentic initiation codon. RNA (1996) 2(9):867-878.
14. Wang TH, Rijnbrand RC, Lemon SM: Core protein-coding sequence, but not core protein, modulates the efficiency of cap-independent translation directed by the internal ribosome entry site of hepatitis C virus. J Virol (2000) 74(23):11347-11358.
15. Hellen CU, Sarnow P: Internal ribosome entry sites in eukaryotic mRNA molecules. Genes Dev (2001) 15(13):1593-1612. Extensive review covering all aspects of internal initiation in viruses and cellular mRNA. This review details the recent work performed in elucidating HCV unique translation strategies.
16. Kieft JS, Zhou K, Grech A, Jubin R, Doudna JA: Crystal structure of an RNA tertiary domain essential to HCV IRES-mediated translation initiation. Nat Struct Biol (2002) 9(5):370-374. Structure of essential IIIabc junction with mutational analysis of the region.
17. Collier AJ, Gallego J, Klinck R, Cole PT, Harris SJ, Harrison GP, Aboul-Ela F, Varani G, Walker S: A conserved RNA structure within the HCV IRES eIF3-binding site. Nat Struct Biol (2002) 9(5):375-380. Structure/mutagenesis of essential eIF3-binding site.
18. Buratti E, Tisminetzky S, Zotti M, Baralle FE: Functional analysis of the interaction between HCV 5′UTR and putative subunits of eukaryotic translation initiation factor eIF3. Nucleic Acids Res (1998) 26(13):3179-3187.
19. Tang S, Collier AJ, Elliott RM: Alterations to both the primary and predicted secondary structure of stem-loop IIIc of the hepatitis C virus 1b 5′ untranslated region (5′UTR) lead to mutants severely defective in translation which cannot be complemented in trans by the wild-type 5′UTR sequence. J Virol (1999) 73(3):2359-2364.
20. Jubin R, Vantuno NE, Kieft JS, Murray MG, Doudna JA, Lau JY, Baroudy BM: Hepatitis C virus internal ribosome entry site (IRES) stem loop IIId contains a phylogenetically conserved GGG triplet essential for translation and IRES folding. J Virol (2000) 74(22):10430-10437.
21. Lukavsky PJ, Otto GA, Lancaster AM, Sarnow P, Puglisi JD: Structures of two RNA domains essential for hepatitis C virus internal ribosome entry site function. Nat Struct Biol (2000) 7(12):1105-1110. One of the first structure-based NMR analyses of IIId and IIIe stem loops.
22. Psaridi L, Georgopoulou U, Varaklioti A, Mavromara P: Mutational analysis of a conserved tetraloop in the 5′ untranslated region of hepatitis C virus identifies a novel RNA element essential for the internal ribosome entry site function. FEBS Lett (1999) 453(1-2):49-53.
23. Honda M, Brown EA, Lemon SM: Stability of a stem-loop involving the initiator AUG controls the efficiency of internal initiation of translation on hepatitis C virus RNA. RNA (1996) 2(10):955-968.
24. Spahn CM, Kieft JS, Grassucci RA, Penczek PA, Zhou K, Doudna JA, Frank J: Hepatitis C virus IRES RNA-induced changes in the conformation of the 40S ribosomal subunit. Science (2001) 291(5510):1959-1962. This review details the structure of the HCV IRES and 40S ribosome complex at 20Å resolution. Important data which allowed for visual confirmation of in vitro binding/mutagenesis studies are reported.
25. Jubin R: Hepatitis C IRES: Translating translation into a therapeutic target. Curr Opin Mol Ther (2001) 3(3):278-287. Comprehensive review of antisense approaches to block HCV.
26. Vos S, Berrisford DJ, Avis JM: Effect of magnesium ions on the tertiary structure of the hepatitis C virus IRES and its affinity for the cyclic peptide antibiotic viomycin. Biochemistry (2002) 41(17):5383-5396. First demonstration of small molecule-IRES RNA interaction.
27. Wang W, Preville P, Morin N, Mounir S, Cai W, Siddiqui MA: Hepatitis C viral IRES inhibition by phenazine and phenazine-like molecules. Bioorg Med Chem Lett (2000) 10(11):1151-1154.
28. 12 blocks HCV translation at the 80S assembly step.
29. Hawkins E, Butler B, Beck M, O'Grady M, Orr L, Wood K: Dual-Glo luciferase assay system: Convenient dual reporter measurements in 96- and 384-well plates. Promega Notes (2002) 81:22-26. Details of the advantages/kinetics of luciferase reporters for high-throughput screening.
30. Kieft JS, Zhou K, Jubin R, Doudna JA: Mechanism of ribosome recruitment by hepatitis C IRES RNA. RNA (2001) 7(2):194-206. In vitro assay system for quantifying IRES-40S or IRES eIF3 interactions.
31. Pestova TV, Shatsky IN, Fletcher SP, Jackson RJ, Hellen CU: A prokaryotic-like mode of cytoplasmic eukaryotic ribosome binding to the initiation codon during internal translation initiation of hepatitis C and classical swine fever virus RNAs. Genes Dev (1998) 12(1):67-83. First mechanistic description of novel HCV IRES-40S and IRES-eIF3 interactions.
32. Xavier KA, Eder PS, Giordano T: RNA as a drug target: Methods for biophysical characterization and screening. Trends Biotechnol (2000) 18(8):349-356. Detailed review highlighting methodologies for targeting and screening RNA ligands.
33. Chow CS, Bogdan FM: A structural basis for RNA-ligand interactions. Chem Rev (1997) 97(5):1489-1514.
34. Klinck R, Westholf E, Walker S, Afshar M, Collier A, Aboul-Ela F: A potential RNA drug target in the hepatitis C virus internal ribosomal entry site. RNA (2000) 6(10):1423-1431. One of the first NMR structure studies of the IIId stem loop.
35. Kim I, Lukavsky PJ, Puglisi JD: NMR study of 100 kDa HCV IRES RNA using segmental isotope labeling. J Am Chem Soc (2002) 124:9338-9339. Study showing NMR structure of entire IRES. Opens up the way for more advanced studies in determining the detailed structure of larger IRES domains.